Hepatology International

, Volume 7, Issue 3, pp 901–909 | Cite as

The effects of intraoperative cryoprecipitate transfusion on acute renal failure following orthotropic liver transplantation

  • Shuang Liu
  • Xiaoliang Wang
  • Yuanshan Lu
  • Tao Li
  • Zijun Gong
  • Tao Sheng
  • Bin Hu
  • Zhihai Peng
  • Xing Sun
Original Article



The definition of risk factors associated with acute renal failure (ARF) following orthotropic liver transplantation (OLT) is still controversial. Cryoprecipitate, which can supply fibrinogen and other coagulation factors, is widely used in OLT. However, the effects of intraoperative cryoprecipitate transfusion on ARF following OLT remain unclear.


In a series of 389 adult patients who received grafts from deceased donors and underwent their first OLT, the clinical correlation between intraoperative cryoprecipitate transfusion and ARF following OLT was retrospectively studied after adjusting for potential confounders. The distribution of ARF and the causes of death within the first year after OLT were also compared separately in patients with and without cryoprecipitate transfusion.


The incidence of ARF in patients with cryoprecipitate transfusion was significantly higher than in patients without cryoprecipitate transfusion (15.9 vs. 7.8 %, p = 0.012). A nonlinear relationship between intraoperative cryoprecipitate transfusion and ARF following OLT was observed. The risk of ARF increased with the cryoprecipitate transfusion level up to the turning point (16 U) (adjusted OR 1.1, 95 % CI 1.1–1.2; p < 0.001). When the cryoprecipitate level exceeded 16 U, the level of cryoprecipitate transfusion was not associated with the risk of ARF (OR 0.95, 95 % CI 0.85–1.1; p = 0.319). Deaths within the first year after the operation occurred more frequently in cases with cryoprecipitate transfusion (22.9 vs. 14.2 %, p = 0.029).


These findings suggested that intraoperative cryoprecipitate transfusion is associated with ARF following OLT. Cryoprecipitate transfusion during OLT should be performed carefully until more convincing evidence has been found.


Transfusion Cryoprecipitate Acute renal failure Liver transplantation 



We gratefully acknowledge Prof. Changzhong Chen from Harvard Medical School for the assistance with statistics. This work was supported by a grant from the National Natural Science Foundation of China (81170445).

Conflict of interest

Shuang Liu, Xiaoliang Wang, Yuanshan Lu, Tao Li, Zijun Gong, Tao Sheng, Bin Hu, Zhihai Peng and Xing Sun declare that they have no conflicts of interest.

Compliance with Ethics Requirements

All procedures followed were in accordance with the ethical standards of the responsible committee on human experimentation (institutional and national) and with the Helsinki Declaration of 1975, as revised in 2008. Due to the retrospective nature of the study, this article did not involve any studies with human or animal subjects. National legislation and the ethics committee of Shanghai First People’s Hospital approved this retrospective study.


  1. 1.
    McCauley J, Van Thiel DH, Starzl TE, Puschett JB. Acute and chronic renal failure in liver transplantation. Nephron 1990;55(2):121–128Google Scholar
  2. 2.
    O’Riordan A, Wong V, McQuillan R, McCormick PA, Hegarty JE, Watson AJ. Acute renal disease, as defined by the RIFLE criteria, post-liver transplantation. Am J Transplant 2007;7(1):168–176. doi: 10.1111/j.1600-6143.2006.01602.x Google Scholar
  3. 3.
    Lima EQ, Zanetta DM, Castro I, Massarollo PC, Mies S, Machado MM, Yu L, et al. Risk factors for development of acute renal failure after liver transplantation. Renal Fail 2003;25(4):553–560Google Scholar
  4. 4.
    Guitard J, Cointault O, Kamar N, Muscari F, Lavayssiere L, Suc B, Ribes D, et al. Acute renal failure following liver transplantation with induction therapy. Clin Nephrol 2006;65(2):103–112Google Scholar
  5. 5.
    Bilbao I, Charco R, Balsells J, Lazaro JL, Hidalgo E, Llopart L, Murio E, et al. Risk factors for acute renal failure requiring dialysis after liver transplantation. Clin Transplant 1998;12(2):123–129Google Scholar
  6. 6.
    Gonwa TA, Mai ML, Melton LB, Hays SR, Goldstein RM, Levy MF, Klintmalm GB Renal replacement therapy and orthotopic liver transplantation: the role of continuous veno-venous hemodialysis. Transplantation 2001;71(10):1424–1428Google Scholar
  7. 7.
    Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, Levy MF, Klintmalm GB Acute kidney injury following liver transplantation: definition and outcome. Liver Transplant 2009;15(5):475–483. doi: 10.1002/lt.21682 Google Scholar
  8. 8.
    Chen J, Singhapricha T, Hu KQ, Hong JC, Steadman RH, Busuttil RW, Xia VW Postliver transplant acute renal injury and failure by the RIFLE criteria in patients with normal pretransplant serum creatinine concentrations: a matched study. Transplantation 2011;91(3):348–353. doi: 10.1097/TP.0b013e31820437da Google Scholar
  9. 9.
    Cabezuelo JB, Ramirez P, Rios A, Acosta F, Torres D, Sansano T, Pons JA, et al. Risk factors of acute renal failure after liver transplantation. Kidney Int 2006;69(6):1073–1080. doi: 10.1038/ Google Scholar
  10. 10.
    Wyatt CM, Arons RR. The burden of acute renal failure in nonrenal solid organ transplantation. Transplantation 2004;78(9):1351–1355Google Scholar
  11. 11.
    Planinsic RM, Sakai T, Hilmi IA. Acute Kidney Injury After Liver Transplantation. Liver Anesthesiology and Critical Care Medicine. New York: Springer; 2012. 383–387Google Scholar
  12. 12.
    Barri YM, Sanchez EQ, Jennings LW, Melton LB, Hays S, Levy MF, Klintmalm GB. Acute kidney injury following liver transplantation: definition and outcome. Liver Transplant 2009;15(5):475–483CrossRefGoogle Scholar
  13. 13.
    Massicotte L, Sassine M-P, Lenis S, Seal RF, Roy A. Survival rate changes with transfusion of blood products during liver transplantation. Can J Anesth 2005;52(2):148–155CrossRefGoogle Scholar
  14. 14.
    Fusai G, Dhaliwal P, Rolando N, Sabin CA, Patch D, Davidson BR, Burroughs AK. Incidence and risk factors for the development of prolonged and severe intrahepatic cholestasis after liver transplantation. Liver Transplant 2006;12(11):1626–1633CrossRefGoogle Scholar
  15. 15.
    de Boer MT, Christensen MC, Asmussen M, van der Hilst CS, Hendriks HG, Slooff MJ, Porte RJ. The impact of intraoperative transfusion of platelets and red blood cells on survival after liver transplantation. Anesth Analg 2008;106(1):32–44CrossRefPubMedGoogle Scholar
  16. 16.
    Bellomo R, Ronco C, Kellum JA, Mehta RL, Palevsky P. Acute renal failure: definition, outcome measures, animal models, fluid therapy and information technology needs: the second international consensus conference of the acute dialysis quality initiative (ADQI) group. Crit Care 2004;8(4):R204CrossRefPubMedGoogle Scholar
  17. 17.
    Pawarode A, Fine DM, Thuluvath PJ. Independent risk factors and natural history of renal dysfunction in liver transplant recipients. Liver Transplant 2003;9(7):741–747. doi: 10.1053/jlts.2003.50113
  18. 18.
    Stone AM, Stein T, LaFortune J, Wise L. Changes in intrarenal blood flow during sepsis. Surg Gynecol Obstet 1979;148(5):731–734Google Scholar
  19. 19.
    Zager RA. Escherichia coli endotoxin injections potentiate experimental ischemic renal injury. Am J Physiol 1986;251(6 Pt 2):F988–F994Google Scholar
  20. 20.
    Rull R, Garcia-Valdecasas J, Grande L, Tabet J, Fuster J, Lacy A, Lacy AM, et al., editors. Outcome after liver transplantation. Differences between two time periods: 1988–1991 and 1992–1995. In Transplantation proceedings; 1997Google Scholar
  21. 21.
    Aggarwal S, Kang Y, Freeman J, Fortunato F, Pinsky M, editors. Postreperfusion syndrome: cardiovascular collapse following hepatic reperfusion during liver transplantation. In Transplantation proceedings; 1987Google Scholar
  22. 22.
    Contreras G, Garces G, Quartin AA, Cely C, LaGatta MA, Barreto GA, Roth D, et al. An epidemiologic study of early renal replacement therapy after orthotopic liver transplantation. J Am Soc Nephrol 2002;13(1):228–233PubMedGoogle Scholar
  23. 23.
    Nair S, Verma S, Thuluvath PJ. Pretransplant renal function predicts survival in patients undergoing orthotopic liver transplantation. Hepatology (Baltimore, MD) 2002;35(5):1179–1185Google Scholar
  24. 24.
    Pool JG, Gershgold EJ, Pappenhagen AR. high-potency antihaemophilic factor concentrate prepared from cryoglobulin precipitate. Nature 1964;203:312Google Scholar
  25. 25.
    Sparrow RL, Greening DW, Simpson RJ. A protocol for the preparation of cryoprecipitate and cryodepleted plasma. Methods Mol Biol (Clifton, NJ) 2011;728:259–265. doi: 10.1007/978-1-61779-068-3_17
  26. 26.
    Lim JK. Chronic liver failure: mechanisms and management. 1st ed. J Clin Gastroenterol 2011;45(10):914. doi: 10.1097/MCG.0b013e31822cf4a5 CrossRefGoogle Scholar
  27. 27.
    O’Shaughnessy DF, Atterbury C, Maggs PB, Murphy M, Thomas D, Yates S, Williamson LM, et al. Guidelines for the use of fresh-frozen plasma, cryoprecipitate and cryosupernatant. Br J Haematol 2004;126(1):11–28. doi: 10.1111/j.1365-2141.2004.04972.x Google Scholar
  28. 28.
    Macphee M, Wilmer B, Beall D, Moroff G. Protein composition of clots detected in pooled cryoprecipitate units. Transfusion; 2012. doi: 10.1111/j.1537-2995.2012.03778.x. PubMed PMID: 22804740
  29. 29.
    Levi M, Toh CH, Thachil J, Watson HG. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology. Br J Haematol 2009;145(1):24–33. doi: 10.1111/j.1365-2141.2009.07600.x
  30. 30.
    Callum JL, Karkouti K, Lin Y. Cryoprecipitate: the current state of knowledge. Transf Med Rev 2009;23(3):177–188. doi: 10.1016/j.tmrv.2009.03.001 Google Scholar
  31. 31.
    Tripodi A, Mannucci PM. The coagulopathy of chronic liver disease. N Engl J Med 2011;365(2):147–156. doi: 10.1056/NEJMra1011170 CrossRefPubMedGoogle Scholar
  32. 32.
    George JN, Pickett EB, Heinz R. Platelet membrane microparticles in blood bank fresh frozen plasma and cryoprecipitate. Blood 1986;68(1):307–309Google Scholar
  33. 33.
    Sprague DL, Elzey BD, Crist SA, Waldschmidt TJ, Jensen RJ, Ratliff TL. Platelet-mediated modulation of adaptive immunity: unique delivery of CD154 signal by platelet-derived membrane vesicles. Blood 2008;111(10):5028–5036. doi: 10.1182/blood-2007-06-097410 Google Scholar
  34. 34.
    Singh N, Gayowski T, Wagener MM. Posttransplantation dialysis-associated infections: morbidity and impact on outcome in liver transplant recipients. Liver Transplant 2001;7(2):100–105. doi: 10.1053/jlts.2001.21304 CrossRefPubMedGoogle Scholar
  35. 35.
    Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 2003;14(8):2178–2187Google Scholar
  36. 36.
    Mehta RL, Kellum JA, Shah SV, Molitoris BA, Ronco C, Warnock DG, Levin A Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care (Lond, Engl) 2007;11(2):R31. doi: 10.1186/cc5713
  37. 37.
    Tanabe M, Kawachi S, Obara H, Shinoda M, Hibi T, Kitagawa Y, et al. Current progress in ABO-incompatible liver transplantation. Eur J Clin Investig 2010;40(10):943–949. doi: 10.1111/j.1365-2362.2010.02339.x Google Scholar
  38. 38.
    Hanto DW, Fecteau AH, Alonso MH, Valente JF, Whiting JF. ABO-incompatible liver transplantation with no immunological graft losses using total plasma exchange, splenectomy, and quadruple immunosuppression: evidence for accommodation. Liver Transplant 2003;9(1):22–30. doi: 10.1053/jlts.2003.50011
  39. 39.
    Busquets J, Castellote J, Torras J, Fabregat J, Ramos E, Llado L, Rafecas A, et al. Liver transplantation across Rh blood group barriers increases the risk of biliary complications. J Gastrointest Surg 2007;11(4):458–463. doi: 10.1007/s11605-007-0116-0 Google Scholar
  40. 40.
    Toso C, Al-Qahtani M, Alsaif FA, Bigam DL, Meeberg GA, James Shapiro AM, Bain VG, et al. ABO-incompatible liver transplantation for critically ill adult patients. Transpl Int 2007;20(8):675–681. doi: 10.1111/j.1432-2277.2007.00492.x Google Scholar
  41. 41.
    Mehta RL, Chertow GM. Acute renal failure definitions and classification: time for change? J Am Soc Nephrol 2003;14(8):2178–2187CrossRefPubMedGoogle Scholar
  42. 42.
    Mehta R, Kellum J, Shah S, Molitoris B, Ronco C, Warnock D, Levin A. Acute kidney injury network: report of an initiative to improve outcomes in acute kidney injury. Crit Care 2007;11(2):R31CrossRefPubMedGoogle Scholar
  43. 43.
    Arroyo V, Ginès P, Gerbes AL, Dudley FJ, Gentilini P, Laffi G, Reynolds TB, et al. Definition and diagnostic criteria of refractory ascites and hepatorenal syndrome in cirrhosis. Hepatology (Baltimore, MD) 1996;23(1):164–176Google Scholar
  44. 44.
    Salerno F, Gerbes A, Ginès P, Wong F, Arroyo V. Diagnosis, prevention and treatment of hepatorenal syndrome in cirrhosis. Postgrad Med J 2008;84(998):662–670CrossRefPubMedGoogle Scholar
  45. 45.
    Sorensen B, Bevan D. A critical evaluation of cryoprecipitate for replacement of fibrinogen. Br J Haematol 2010;149(6):834–843. doi: 10.1111/j.1365-2141.2010.08208.x Google Scholar
  46. 46.
    Fenger-Eriksen C, Lindberg-Larsen M, Christensen AQ, Ingerslev J, Sorensen B. Fibrinogen concentrate substitution therapy in patients with massive haemorrhage and low plasma fibrinogen concentrations. Br J Anaesth 2008;101(6):769–773. doi: 10.1093/bja/aen270 Google Scholar

Copyright information

© Asian Pacific Association for the Study of the Liver 2013

Authors and Affiliations

  • Shuang Liu
    • 1
  • Xiaoliang Wang
    • 1
  • Yuanshan Lu
    • 2
  • Tao Li
    • 1
  • Zijun Gong
    • 1
  • Tao Sheng
    • 1
  • Bin Hu
    • 3
  • Zhihai Peng
    • 1
  • Xing Sun
    • 1
  1. 1.Department of General Surgery, Shanghai First People’s Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina
  2. 2.Department of Transfusion, Shanghai First People’s Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina
  3. 3.Department of Gastroenterology, Shanghai First People’s Hospital, School of MedicineShanghai Jiao Tong UniversityShanghaiChina

Personalised recommendations